维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Gerlag DM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	lnhibitor of nuclear factor kB ki- naseb is a key regulator of synovial inflammation显示文摘	Tak PP Gerlag DM Aupperle KR	2001	Arthritis Rheum2001，44，8：	1
2	A randomized con-trolled trial with an anti-CCL2 ( anti-monocyte chemotactic pro-tein 1 ) monoclonal antibody in patients with rheumatoidarthritis显示文摘	Haringman JJ Gerlag DM Smeets TJ	2006	Arthritis Rheum2006，54，8：	1
3	Inhibitor of nuclearfactor kappa B kinase beta is a key regulator of synovial inflammation显示文摘	Tak PP Gerlag DM Aupperle KR	2001	Arthritis Rheum2001，44，8：	1
4	Inhibitor of nuclear factor kappa B kinase beta is a key regulator of synovial inflammation显示文摘	Tak PP Gerlag DM Aupperle KR	2001	Arthritis Rheum2001，44，8：	1
5	Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation显示文摘	Tak PP Gerlag DM Aupperle KR	2001	Arthritis Rheum2001，44，8：	1
6	Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation显示文摘	Tak PP Gerlag DM Aupperle KR	2001	Arthritis Rheum2001，44，8：	1
7	Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation显示文摘	Tak PP Gerlag DM Aupperle KR	2001	Arthritis Rheum2001，44，：	1
8	A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis显示文摘	Gerlag DM Smeets TJ	2006	Arthritis Rheum2006，54，8：	1
9	Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial显示文摘	Vergunst CE Gerlag DM Lopatinskaya L	2008	Arthritis Rheum2008，58，7：	1
10	Synovial tissue analysis for the discovery of diagnostic and prognostic biomarkers in patients with early arthritis显示文摘	de Hair MJ Harty LC Gerlag DM		0，，09：	1
11	Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation 显示文摘	Vergunst CE Gerlag DM Dinant H	2007	Rheumatology (Oxford)2007，46，：	1
12	Novel approaches for the treatment ofrheumatoid arthritis:lessons from the evaluation of synovialbiomarkers in clinical trials显示文摘	Gerlag DM Tak PP	2008	Best Pract Res Clin Rheumatol2008，22，2：	1
13	Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature显示文摘	Gerlag DM Borges E Tak PP	2001	Arthritis Res2001，3，：	1
14	Inhibitor of nuclear factor kB kinase b is a key regulator of synovial inflammation显示文摘	Tak PP Gerlag DM Aupperle KR	2001	Arthritis Rheum2001，44，8：	1
15	A phase Ⅱ a, randomized, double-blind, placebo controlled trial of apili- mod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis 显示文摘	Krausz S Boumans MJ Gerlag DM	2012	Arthritis Rheum2012，64，6：	1
16	The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine produc- tion and collagen-induced arthritis 显示文摘	Gerlag DM Ransone L Tak PP	2000	Jlmmunol2000，165，3：	1
17	Body mass index and clinical response to infliximab in rheumatoid arthritis显示文摘	Klaasen R Wijbrandts CA Gerlag DM		0，，02：	1
18	Synovial tissue macrophages: a sensitive biomarker for response to treat- ment in patients with rheumatoid arthritis显示文摘	Haringman JJ Gerlag DM Zwinderman AH	2005	Ann Rheum Dis2005，64，6：	1
19	Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisafion to be used in clinical trials 显示文摘	van de Sande MG Gerlag DM Lodde Bbl	2011	Ann Rheum Dis2011，70，3：	1
20	Inhibitor of nuclear factor κappaB kinase beta is a key regulator of synovial inflammation显示文摘	Tak PP Gerlag DM Aupperle KR	2001	Arthritis Rheum2001，44，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示